EVAX
Price
$0.82
Change
+$0.02 (+2.50%)
Updated
Dec 1, 6:59 PM EST
121 days until earnings call
FRTX
Price
$0.82
Change
-$0.03 (-3.53%)
Updated
Dec 1, 6:59 PM EST
108 days until earnings call
Ad is loading...

Analysis and predictions EVAX vs FRTX

Header iconEVAX vs FRTX Comparison
Open Charts EVAX vs FRTXBanner chart's image
Evaxion Biotech A/S American Depositary Share
Price$0.82
Change+$0.02 (+2.50%)
Volume$27.51K
CapitalizationN/A
Fresh Tracks Therapeutics
Price$0.82
Change-$0.03 (-3.53%)
Volume$6.85K
CapitalizationN/A
View a ticker or compare two or three
EVAX vs FRTX Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
EVAX vs. FRTX commentary
Dec 03, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVAX is a Hold and FRTX is a StrongBuy.

COMPARISON
Comparison
Dec 03, 2023
Stock price -- (EVAX: $0.82 vs. FRTX: $0.82)
Brand notoriety: EVAX and FRTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EVAX: 46% vs. FRTX: 28%
Market capitalization -- EVAX: $22.61M vs. FRTX: $4.63M
EVAX [@Biotechnology] is valued at $22.61M. FRTX’s [@Biotechnology] market capitalization is $4.63M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EVAX’s FA Score shows that 0 FA rating(s) are green whileFRTX’s FA Score has 1 green FA rating(s).

  • EVAX’s FA Score: 0 green, 5 red.
  • FRTX’s FA Score: 1 green, 4 red.
According to our system of comparison, FRTX is a better buy in the long-term than EVAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EVAX’s TA Score shows that 2 TA indicator(s) are bullish while FRTX’s TA Score has 5 bullish TA indicator(s).

  • EVAX’s TA Score: 2 bullish, 7 bearish.
  • FRTX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, FRTX is a better buy in the short-term than EVAX.

Price Growth

EVAX (@Biotechnology) experienced а -4.64% price change this week, while FRTX (@Biotechnology) price change was +4.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.15%. For the same industry, the average monthly price growth was +30.64%, and the average quarterly price growth was +27.15%.

Reported Earning Dates

EVAX is expected to report earnings on Apr 02, 2024.

FRTX is expected to report earnings on Mar 20, 2024.

Industries' Descriptions

@Biotechnology (+3.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for EVAX with price predictions.
OPEN
A.I.dvisor published
a Summary for FRTX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
EVAX($22.6M) has a higher market cap than FRTX($4.63M). FRTX YTD gains are higher at: -45.327 vs. EVAX (-53.803). FRTX has higher annual earnings (EBITDA): -8.94M vs. EVAX (-24.28M). FRTX has more cash in the bank: 12M vs. EVAX (7.12M). FRTX has less debt than EVAX: FRTX (0) vs EVAX (10.5M). FRTX has higher revenues than EVAX: FRTX (10.1M) vs EVAX (0).
EVAXFRTXEVAX / FRTX
Capitalization22.6M4.63M488%
EBITDA-24.28M-8.94M272%
Gain YTD-53.803-45.327119%
P/E RatioN/AN/A-
Revenue010.1M-
Total Cash7.12M12M59%
Total Debt10.5M0-
TECHNICAL ANALYSIS
Technical Analysis
EVAXFRTX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 13 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KRC35.412.43
+7.37%
Kilroy Realty Corp
ARLO9.460.37
+4.07%
Arlo Technologies
TRKA1.210.03
+2.54%
Troika Media Group
TTD71.601.14
+1.62%
Trade Desk (The)
NAK0.33N/A
+0.48%
Northern Dynasty Minerals Ltd

EVAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, EVAX has been loosely correlated with ATRA. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if EVAX jumps, then ATRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EVAX
1D Price
Change %
EVAX100%
+2.63%
ATRA - EVAX
40%
Loosely correlated
-1.85%
IKNA - EVAX
28%
Poorly correlated
+3.45%
NRIX - EVAX
28%
Poorly correlated
+11.09%
SPRB - EVAX
27%
Poorly correlated
+6.43%
DNLI - EVAX
26%
Poorly correlated
+2.43%
More

FRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, FRTX has been loosely correlated with LXRX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if FRTX jumps, then LXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FRTX
1D Price
Change %
FRTX100%
-2.95%
LXRX - FRTX
42%
Loosely correlated
+8.49%
DRTS - FRTX
38%
Loosely correlated
-3.66%
CALC - FRTX
37%
Loosely correlated
-5.30%
ALNY - FRTX
29%
Poorly correlated
+1.88%
BGNE - FRTX
28%
Poorly correlated
+0.29%
More